Global PEGylated Protein Therapeutics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
- GLO2771844
- 0 Pages
- September 2018
- Medical Devices
Scope of the Report:
This report studies the PEGylated Protein Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the PEGylated Protein Therapeutics market by product type and applications/end industries.
Higher process cost associated with PEGylation and patent expiry of certain drugs are projected to hinder the market growth.
The global PEGylated Protein Therapeutics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of PEGylated Protein Therapeutics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Merck
Pfizer
UCB
Amgen
AstraZeneca
Biogen
Roche
Horizon Pharma
Leadiant Biosciences
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Colony Stimulating Factor
Interferon
Erythropoietin (EPO)
Recombinant Factor VIII
Monoclonal Antibody
Enzyme
Others
Market Segment by Applications, can be divided into
Cancer
Autoimmune Disease
Hepatitis
Multiple Sclerosis
Hemophilia
Gastrointestinal Disorder
Others
1 PEGylated Protein Therapeutics Market Overview
1.1 Product Overview and Scope of PEGylated Protein Therapeutics
1.2 Classification of PEGylated Protein Therapeutics by Types
1.2.1 Global PEGylated Protein Therapeutics Revenue Comparison by Types (2017-2023)
1.2.2 Global PEGylated Protein Therapeutics Revenue Market Share by Types in 2017
1.2.3 Colony Stimulating Factor
1.2.4 Interferon
1.2.5 Erythropoietin (EPO)
1.2.6 Recombinant Factor VIII
1.2.7 Monoclonal Antibody
1.2.8 Enzyme
1.2.9 Others
1.3 Global PEGylated Protein Therapeutics Market by Application
1.3.1 Global PEGylated Protein Therapeutics Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Cancer
1.3.3 Autoimmune Disease
1.3.4 Hepatitis
1.3.5 Multiple Sclerosis
1.3.6 Hemophilia
1.3.7 Gastrointestinal Disorder
1.3.8 Others
1.4 Global PEGylated Protein Therapeutics Market by Regions
1.4.1 Global PEGylated Protein Therapeutics Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) PEGylated Protein Therapeutics Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) PEGylated Protein Therapeutics Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) PEGylated Protein Therapeutics Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) PEGylated Protein Therapeutics Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) PEGylated Protein Therapeutics Status and Prospect (2013-2023)
1.5 Global Market Size of PEGylated Protein Therapeutics (2013-2023)
2 Manufacturers Profiles
2.1 Merck
2.1.1 Business Overview
2.1.2 PEGylated Protein Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Merck PEGylated Protein Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.2 Pfizer
2.2.1 Business Overview
2.2.2 PEGylated Protein Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Pfizer PEGylated Protein Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.3 UCB
2.3.1 Business Overview
2.3.2 PEGylated Protein Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 UCB PEGylated Protein Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.4 Amgen
2.4.1 Business Overview
2.4.2 PEGylated Protein Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Amgen PEGylated Protein Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.5 AstraZeneca
2.5.1 Business Overview
2.5.2 PEGylated Protein Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 AstraZeneca PEGylated Protein Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.6 Biogen
2.6.1 Business Overview
2.6.2 PEGylated Protein Therapeutics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Biogen PEGylated Protein Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.7 Roche
2.7.1 Business Overview
2.7.2 PEGylated Protein Therapeutics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Roche PEGylated Protein Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.8 Horizon Pharma
2.8.1 Business Overview
2.8.2 PEGylated Protein Therapeutics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Horizon Pharma PEGylated Protein Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.9 Leadiant Biosciences
2.9.1 Business Overview
2.9.2 PEGylated Protein Therapeutics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Leadiant Biosciences PEGylated Protein Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
3 Global PEGylated Protein Therapeutics Market Competition, by Players
3.1 Global PEGylated Protein Therapeutics Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 PEGylated Protein Therapeutics Players Market Share
3.2.2 Top 10 PEGylated Protein Therapeutics Players Market Share
3.3 Market Competition Trend
4 Global PEGylated Protein Therapeutics Market Size by Regions
4.1 Global PEGylated Protein Therapeutics Revenue and Market Share by Regions
4.2 North America PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
4.3 Europe PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
4.5 South America PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
5 North America PEGylated Protein Therapeutics Revenue by Countries
5.1 North America PEGylated Protein Therapeutics Revenue by Countries (2013-2018)
5.2 USA PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
5.3 Canada PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
5.4 Mexico PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
6 Europe PEGylated Protein Therapeutics Revenue by Countries
6.1 Europe PEGylated Protein Therapeutics Revenue by Countries (2013-2018)
6.2 Germany PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
6.3 UK PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
6.4 France PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
6.5 Russia PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
6.6 Italy PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
7 Asia-Pacific PEGylated Protein Therapeutics Revenue by Countries
7.1 Asia-Pacific PEGylated Protein Therapeutics Revenue by Countries (2013-2018)
7.2 China PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
7.3 Japan PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
7.4 Korea PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
7.5 India PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
8 South America PEGylated Protein Therapeutics Revenue by Countries
8.1 South America PEGylated Protein Therapeutics Revenue by Countries (2013-2018)
8.2 Brazil PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
8.3 Argentina PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
8.4 Colombia PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue PEGylated Protein Therapeutics by Countries
9.1 Middle East and Africa PEGylated Protein Therapeutics Revenue by Countries (2013-2018)
9.2 Saudi Arabia PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
9.3 UAE PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
9.4 Egypt PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
9.5 Nigeria PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
9.6 South Africa PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
10 Global PEGylated Protein Therapeutics Market Segment by Type
10.1 Global PEGylated Protein Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Global PEGylated Protein Therapeutics Market Forecast by Type (2018-2023)
10.3 Colony Stimulating Factor Revenue Growth Rate (2013-2023)
10.4 Interferon Revenue Growth Rate (2013-2023)
10.5 Erythropoietin (EPO) Revenue Growth Rate (2013-2023)
10.6 Recombinant Factor VIII Revenue Growth Rate (2013-2023)
10.7 Monoclonal Antibody Revenue Growth Rate (2013-2023)
10.8 Enzyme Revenue Growth Rate (2013-2023)
10.9 Others Revenue Growth Rate (2013-2023)
11 Global PEGylated Protein Therapeutics Market Segment by Application
11.1 Global PEGylated Protein Therapeutics Revenue Market Share by Application (2013-2018)
11.2 PEGylated Protein Therapeutics Market Forecast by Application (2018-2023)
11.3 Cancer Revenue Growth (2013-2018)
11.4 Autoimmune Disease Revenue Growth (2013-2018)
11.5 Hepatitis Revenue Growth (2013-2018)
11.6 Multiple Sclerosis Revenue Growth (2013-2018)
11.7 Hemophilia Revenue Growth (2013-2018)
11.8 Gastrointestinal Disorder Revenue Growth (2013-2018)
11.9 Others Revenue Growth (2013-2018)
12 Global PEGylated Protein Therapeutics Market Size Forecast (2018-2023)
12.1 Global PEGylated Protein Therapeutics Market Size Forecast (2018-2023)
12.2 Global PEGylated Protein Therapeutics Market Forecast by Regions (2018-2023)
12.3 North America PEGylated Protein Therapeutics Revenue Market Forecast (2018-2023)
12.4 Europe PEGylated Protein Therapeutics Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific PEGylated Protein Therapeutics Revenue Market Forecast (2018-2023)
12.6 South America PEGylated Protein Therapeutics Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa PEGylated Protein Therapeutics Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure PEGylated Protein Therapeutics Picture
Table Product Specifications of PEGylated Protein Therapeutics
Table Global PEGylated Protein Therapeutics and Revenue (Million USD) Market Split by Product Type
Figure Global PEGylated Protein Therapeutics Revenue Market Share by Types in 2017
Figure Colony Stimulating Factor Picture
Figure Interferon Picture
Figure Erythropoietin (EPO) Picture
Figure Recombinant Factor VIII Picture
Figure Monoclonal Antibody Picture
Figure Enzyme Picture
Figure Others Picture
Table Global PEGylated Protein Therapeutics Revenue (Million USD) by Application (2013-2023)
Figure PEGylated Protein Therapeutics Revenue Market Share by Applications in 2017
Figure Cancer Picture
Figure Autoimmune Disease Picture
Figure Hepatitis Picture
Figure Multiple Sclerosis Picture
Figure Hemophilia Picture
Figure Gastrointestinal Disorder Picture
Figure Others Picture
Table Global Market PEGylated Protein Therapeutics Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America PEGylated Protein Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe PEGylated Protein Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific PEGylated Protein Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America PEGylated Protein Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa PEGylated Protein Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global PEGylated Protein Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck PEGylated Protein Therapeutics Type and Applications
Table Merck PEGylated Protein Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer PEGylated Protein Therapeutics Type and Applications
Table Pfizer PEGylated Protein Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table UCB Basic Information, Manufacturing Base and Competitors
Table UCB PEGylated Protein Therapeutics Type and Applications
Table UCB PEGylated Protein Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen PEGylated Protein Therapeutics Type and Applications
Table Amgen PEGylated Protein Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca PEGylated Protein Therapeutics Type and Applications
Table AstraZeneca PEGylated Protein Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Biogen Basic Information, Manufacturing Base and Competitors
Table Biogen PEGylated Protein Therapeutics Type and Applications
Table Biogen PEGylated Protein Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche PEGylated Protein Therapeutics Type and Applications
Table Roche PEGylated Protein Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Horizon Pharma Basic Information, Manufacturing Base and Competitors
Table Horizon Pharma PEGylated Protein Therapeutics Type and Applications
Table Horizon Pharma PEGylated Protein Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Leadiant Biosciences Basic Information, Manufacturing Base and Competitors
Table Leadiant Biosciences PEGylated Protein Therapeutics Type and Applications
Table Leadiant Biosciences PEGylated Protein Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Global PEGylated Protein Therapeutics Revenue (Million USD) by Players (2013-2018)
Table Global PEGylated Protein Therapeutics Revenue Share by Players (2013-2018)
Figure Global PEGylated Protein Therapeutics Revenue Share by Players in 2016
Figure Global PEGylated Protein Therapeutics Revenue Share by Players in 2017
Figure Global Top 5 Players PEGylated Protein Therapeutics Revenue Market Share in 2017
Figure Global Top 10 Players PEGylated Protein Therapeutics Revenue Market Share in 2017
Figure Global PEGylated Protein Therapeutics Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global PEGylated Protein Therapeutics Revenue (Million USD) by Regions (2013-2018)
Table Global PEGylated Protein Therapeutics Revenue Market Share by Regions (2013-2018)
Figure Global PEGylated Protein Therapeutics Revenue Market Share by Regions (2013-2018)
Figure Global PEGylated Protein Therapeutics Revenue Market Share by Regions in 2017
Figure North America PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
Figure Europe PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
Figure South America PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
Table North America PEGylated Protein Therapeutics Revenue by Countries (2013-2018)
Table North America PEGylated Protein Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America PEGylated Protein Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America PEGylated Protein Therapeutics Revenue Market Share by Countries in 2017
Figure USA PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
Figure Canada PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
Figure Mexico PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
Table Europe PEGylated Protein Therapeutics Revenue (Million USD) by Countries (2013-2018)
Figure Europe PEGylated Protein Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Europe PEGylated Protein Therapeutics Revenue Market Share by Countries in 2017
Figure Germany PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
Figure UK PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
Figure France PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
Figure Russia PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
Figure Italy PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
Table Asia-Pacific PEGylated Protein Therapeutics Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific PEGylated Protein Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific PEGylated Protein Therapeutics Revenue Market Share by Countries in 2017
Figure China PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
Figure Japan PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
Figure Korea PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
Figure India PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
Figure Southeast Asia PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
Table South America PEGylated Protein Therapeutics Revenue by Countries (2013-2018)
Table South America PEGylated Protein Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America PEGylated Protein Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America PEGylated Protein Therapeutics Revenue Market Share by Countries in 2017
Figure Brazil PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
Figure Argentina PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
Figure Colombia PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
Table Middle East and Africa PEGylated Protein Therapeutics Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa PEGylated Protein Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa PEGylated Protein Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa PEGylated Protein Therapeutics Revenue Market Share by Countries in 2017
Figure Saudi Arabia PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
Figure UAE PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
Figure Egypt PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
Figure Nigeria PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
Figure South Africa PEGylated Protein Therapeutics Revenue and Growth Rate (2013-2018)
Table Global PEGylated Protein Therapeutics Revenue (Million USD) by Type (2013-2018)
Table Global PEGylated Protein Therapeutics Revenue Share by Type (2013-2018)
Figure Global PEGylated Protein Therapeutics Revenue Share by Type (2013-2018)
Figure Global PEGylated Protein Therapeutics Revenue Share by Type in 2017
Table Global PEGylated Protein Therapeutics Revenue Forecast by Type (2018-2023)
Figure Global PEGylated Protein Therapeutics Market Share Forecast by Type (2018-2023)
Figure Global Colony Stimulating Factor Revenue Growth Rate (2013-2018)
Figure Global Interferon Revenue Growth Rate (2013-2018)
Figure Global Erythropoietin (EPO) Revenue Growth Rate (2013-2018)
Figure Global Recombinant Factor VIII Revenue Growth Rate (2013-2018)
Figure Global Monoclonal Antibody Revenue Growth Rate (2013-2018)
Figure Global Enzyme Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Table Global PEGylated Protein Therapeutics Revenue by Application (2013-2018)
Table Global PEGylated Protein Therapeutics Revenue Share by Application (2013-2018)
Figure Global PEGylated Protein Therapeutics Revenue Share by Application (2013-2018)
Figure Global PEGylated Protein Therapeutics Revenue Share by Application in 2017
Table Global PEGylated Protein Therapeutics Revenue Forecast by Application (2018-2023)
Figure Global PEGylated Protein Therapeutics Market Share Forecast by Application (2018-2023)
Figure Global Cancer Revenue Growth Rate (2013-2018)
Figure Global Autoimmune Disease Revenue Growth Rate (2013-2018)
Figure Global Hepatitis Revenue Growth Rate (2013-2018)
Figure Global Multiple Sclerosis Revenue Growth Rate (2013-2018)
Figure Global Hemophilia Revenue Growth Rate (2013-2018)
Figure Global Gastrointestinal Disorder Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Figure Global PEGylated Protein Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global PEGylated Protein Therapeutics Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global PEGylated Protein Therapeutics Revenue Market Share Forecast by Regions (2018-2023)
Figure North America PEGylated Protein Therapeutics Revenue Market Forecast (2018-2023)
Figure Europe PEGylated Protein Therapeutics Revenue Market Forecast (2018-2023)
Figure Asia-Pacific PEGylated Protein Therapeutics Revenue Market Forecast (2018-2023)
Figure South America PEGylated Protein Therapeutics Revenue Market Forecast (2018-2023)
Figure Middle East and Africa PEGylated Protein Therapeutics Revenue Market Forecast (2018-2023)
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
